MEPROGEST
MEPROGEST
Discontinued
DIN Number
02212056
Drug Class
Human
Market Date
N/A
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02212056
AIG Number0106339004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G03DA02 MEDROXYPROGESTERONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:32.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
MEDROXYPROGESTERONE ACETATEActive
Strength: 2.5 MG
Monograph: MEDROXYPROGESTERONE ACETATE